2019 journal article
Evaluation of the Tolerability of Combination Chemotherapy with Mitoxantrone and Dacarbazine in Dogs with Lymphoma
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 55(2), 101–109.
MeSH headings : Animals; Antineoplastic Agents / administration & dosage; Antineoplastic Agents / adverse effects; Antineoplastic Agents / therapeutic use; Antineoplastic Combined Chemotherapy Protocols / therapeutic use; Dacarbazine / administration & dosage; Dacarbazine / adverse effects; Dacarbazine / therapeutic use; Dog Diseases / drug therapy; Dogs; Dose-Response Relationship, Drug; Female; Lymphoma / drug therapy; Lymphoma / veterinary; Male; Mitoxantrone / administration & dosage; Mitoxantrone / adverse effects; Mitoxantrone / therapeutic use; Neutropenia / chemically induced; Neutropenia / veterinary; Retrospective Studies
TL;DR:
The combination of mitoxantrone and DTIC is a safe treatment option for resistant lymphoma in dogs.
(via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being
(Web of Science; OpenAlex)
Source: Web Of Science
Added: March 4, 2019
ABSTRACT